| Code |
| DGNS |
| Title |
| PT Diagnos Laboratorium Utama Tbk |
| Address |
| Head Office | : | | | Address | : | Gedung Graha Anam 2th Floor, Jl. Teuku Cik Ditiro No.11 A,B,C | | | Kelurahan Gondangdia, Kecamatan Menteng, Jakarta Pusat 10350 | | Phone | : | (021) 3193 1883 | | Fax | : | - | | E-mail | : | corsec@diagnos.co.id | | Website | : | www.diagnos.co.id |
|
| Background |
The Company’s scope of activities is engaged in providing health support services, such as health laboratories, other diagnostic drawing centers, blood testing laboratories, pharmaceutical warehouse, eye banks, sperm bank and blood banks, organ transplant banks and other medical support services. |
| Business cp product |
The Company’s scope of activities is engaged in providing health support services, such as health laboratories, other diagnostic drawing centers, blood testing laboratories, pharmaceutical warehouse, eye banks, sperm bank and blood banks, organ transplant banks and other medical support services. |
| Subsidiary affiliation |
|
| Commissioners |
| President Commissioner | : Ivan Rizal Sini | | | Commissioner | : Nurhadi Yudiyantho | | | Independent Commissioner | : Martinus Eliatulo Zega | | | | | | Per 30 Sep 2023 | | |
|
| Directors |
| President Director | : Ir. Mesha Rizal Sini | | | Director | : Dennis Jacobus | | | Director | Renobulan Rizal Sini Suheimi | | | Director | : Fergus Richard | | | Director | : Dilly Dwiasri | | | | | | Per 30 Sep 2023 | | |
|
| Underwriter |
| PT. Mirae Asset Sekuritas Indonesia | |
| Share registrar |
| PT. Adimitra Jasa Korpora | |
| Share holders |
| Shareholders | Shares | % | | | | PT Bunda Investama Indonesia | 485000000 | 38.8 | | | | PT Bundamedik | 515000000 | 41.2 | | | | Public | 250000000 | 20 | | | | | | | | | As of Sep 30, 2023 | | | | |
|
| History stocks |
Type of ListingDatePrice## of SharesTotal Listed Shares IPO @ Rp 20015-Jan-2021252500000001250000000
|
| Other infos |
|
| Created date |
| 2023-11-09 11:06:38 |
| Revised date |
| 2023-11-09 11:06:38 |
| Finance |
| PT Diagnos Laboratorium Utama Tbk |
| Financial Statetment Date |
| Fiscal Year Ends |
| Months Covered in Income St |
| |
| Summary Covered in Income St |
| Cash and Cash Equivalents |
| Receivables |
| Inventories |
| Current Assets |
| Fixed Assets |
| Other Assets |
| Non Current Assets |
| Total Assets |
| Current Liabilities |
| Longterm Liabilities |
| Total Liabilities |
| Authorized |
| Paid-up Capital |
| Par Value |
| Paid-up Capital Shares |
| Retained Earnings |
| Total Equity |
| Minority Interest |
| |
| Summary of Income Statement |
| Total Sales |
| Cost of Good Sold |
| Gross Profit |
| Operating Profit |
| Other Income |
| Earning Before Tax |
| Tax |
| Net Income |
| Close Price |
| |
| Per Share Data (Rp) |
| Eps (annualized) |
| Book Value |
| |
| Financial Ratios |
| Debt Equity Ratio (X) |
| Roa(%) |
| Roe(%) |
| Npm(%) |
| Opm(%) |
| Gross Profit Margin (%) |
| Total Assets Turnover |
| |
| Cash Flow |
| CF from Operation Activities |
| CF from Investing Activities |
| CF from Financing Activities |
| Net Increase in Cash & Cash Equivalent |
| Cash & Cash Equivalent at Beginning of the Year |
| Cash & Cash Equivalent at The End of the Year |
|
|